Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
- PMID: 20162686
- PMCID: PMC3059586
- DOI: 10.1002/pbc.22434
Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
Abstract
We reviewed clinicopathologic features and treatment outcomes in seven patients diagnosed with Stage 4/Group IV orbital sarcoma and treated on IRSG protocols I-III. Three patients had embryonal rhabdomyosarcoma (RMS), and two patients each had alveolar RMS or unclassified sarcoma. Median age at diagnosis was 1.8 years (range 0.2-6.9 years). All patients had bone marrow involvement, including six with normal complete blood count at diagnosis. Cerebrospinal fluid was normal in six patients. Three patients survived >5 years, including one with local recurrence. In conclusion, further study is needed to determine necessity of bone marrow and CSF examination in orbital sarcoma patients.
Copyright 2010 Wiley-Liss, Inc.
References
-
- Arndt CAS, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med. 1999;341:342–352. - PubMed
-
- Oberlin O, Rey A, Anderson J, et al. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment – results of an international workshop. J Clin Oncol. 2001;19:197–204. - PubMed
-
- Maurer H, Beltangady M, Gehan E, et al. The Intergroup Rhabdomyosarcoma Study – I: a final report. Cancer. 1988;61:209–220. - PubMed
-
- Maurer H, Gehan E, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study – II. Cancer. 1993;71:1904–1922. - PubMed
-
- Crist W, Gehan EA, Ragab AH, et al. The third Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 1995;13:610–630. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
